Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. - Wikidata - awgldk - TriplyDB

Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

http://www.wikidata.org/entity/Q39710412

about

miR-449 inhibits cell proliferation and is down-regulated in gastric cancer The Role of Mir-148a in Cancer Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer Non-coding landscapes of colorectal cancer An update on microRNAs as colorectal cancer biomarkers: where are we and what's next?Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice.Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer.MicroRNA-152 regulates immune response via targeting B7-H1 in gastric carcinoma.Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers.Integrative network analysis reveals active microRNAs and their functions in gastric cancer.MicroRNAs as potential biomarkers for gastric cancer.MiRNA-mediated control of HLA-G expression and function.Inverse association between miR-194 expression and tumor invasion in gastric cancer.microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism.Silencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinoma Analysis of differential miRNA expression in the duodenum of Escherichia coli F18-sensitive and -resistant weaned piglets The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer.MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic tool miR-22 represses cancer progression by inducing cellular senescence miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells.Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer.MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis.Analysis of miRNA expression profiles in breast cancer using biclustering.Clinically relevant microRNAs in ovarian cancer MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer.MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1 MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma.RETRACTED: Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues MicroRNA-148a promotes myogenic differentiation by targeting the ROCK1 gene.Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis.Novel classes of non-coding RNAs and cancer miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.TGF-β induces HLA-G expression through inhibiting miR-152 in gastric cancer cells.Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.

P2860

Q21245766-7281C95D-D9CE-49B2-92D8-BA554113BF5B Q26743549-DC83C7B4-B108-429B-8E08-50AEB6B5AE2D Q26774498-A9904D9A-D253-4749-9A58-F2A669DA72B0 Q26775610-FCEBE6B8-22F9-4C0F-A06A-8C6EE443B815 Q26778014-2B411345-F535-4784-BA09-4DC841AFF081 Q27024427-CEAC4B5E-EB50-4B40-A9FE-503CB5256D11 Q33427174-AEDDBC79-0F8E-4E10-87C8-B6347C63ED8A Q33599015-08191401-47C0-4267-94C0-0405FF48A314 Q33709601-B90D810C-71FB-40D6-8666-A7A21862C6C4 Q33710125-E70E7E36-5305-4101-87D5-89A874142919 Q33942494-F14B4627-7229-485B-8217-8C35D026EAD8 Q34168445-467BF628-CC1C-485B-ADD2-F1BBB0E74050 Q34206215-590BE13C-486B-4F27-BB54-BA04BBB3D7C7 Q34208375-D6EDDFCB-CE31-4FD0-A5E0-DFE8E16C24BD Q34299181-7EA4F375-F96D-4B5C-B308-0CB517F43A8B Q34309924-C7CB344F-D2EF-472E-BC75-BFF9D8D096A6 Q34365798-A7B6E7D3-A6F2-45CC-A464-868CC0D952AD Q34399366-4EAB7AB4-2337-4DD2-B27C-422FB7995251 Q34441849-9DAA02EE-C8A6-4F93-8D87-BE13C391E084 Q34506870-95836EFA-52F9-4CC8-BCD8-3CB93BBF8B15 Q34576658-532C7139-D3E4-40DC-BC5E-F4DD796B445D Q34825182-3E0174B6-A271-4825-813B-FBA4A5708463 Q34941020-47FDA894-0B80-4024-A89D-5382E103BD35 Q35034648-056E7213-8DD4-4AAE-8DC9-C42D2CBAE6AC Q35051475-A055F9A3-8E08-49AC-80A7-A0FD157F5861 Q35141171-E12A5B2F-377D-43B9-8535-82F0D47618AA Q35204609-67FF2D93-270F-47E2-9AF3-0D8526DB2CA2 Q35302023-C24B910F-31A8-41E4-962F-CE38C5CE3254 Q35853031-0AEAF316-194D-4024-825B-2E3DB2E3B872 Q35865575-14E28424-E00E-4CC7-83B4-0B8E147E581A Q35882785-E4B351B6-DB5D-47C4-9282-7576A36B84C3 Q35897271-2732CCF2-9737-4690-B4CC-59EF0905573D Q35926654-88D3EE6F-1BFD-45B6-845D-B25E15AFCFFF Q36033204-2A29A1D2-3546-49E9-BB02-FF047C7DF6AA Q36095261-52684F87-22E0-4081-8759-DFA642F45761 Q36158807-D3225231-FD77-4999-B205-2651CB71D65F Q36209417-60F4E445-218B-4E39-AC8E-70A65E6F9520 Q36281362-75BC5959-ED8F-49BD-BA63-679D08A508E6 Q36340968-EE856B8B-2C3B-40E6-92F8-BB34693AC77F Q36580378-35580F4B-7E60-4FEE-B3CD-51AEDA35EF15

P2860

Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

http://www.wikidata.org/entity/Q39710412

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Altered expression of MiR-148a ...... and its clinical significance.

@en

Altered expression of MiR-148a ...... and its clinical significance.

@nl

type

label

Altered expression of MiR-148a ...... and its clinical significance.

@en

Altered expression of MiR-148a ...... and its clinical significance.

@nl

prefLabel

Altered expression of MiR-148a ...... and its clinical significance.

@en

Altered expression of MiR-148a ...... and its clinical significance.

@nl

P1433

Q39710412-0F241E67-0E9B-4A77-B5AE-BA9AF1021039

P1476

Q39710412-1942D2D4-820E-4302-A044-E2F52FDBEE11

P2093

Q39710412-0D82555B-D40E-465B-977D-C33114FFE557

Q39710412-4BB38196-4033-43AD-8D44-A0F11F7945E2

Q39710412-E19037B2-A116-44A1-9DA5-AF1924CE0568

Q39710412-E27BCE90-4C83-4FA6-8521-510C9BB66A11

Q39710412-E2B0E602-C4DA-470F-A60A-C36EBB430EAA

Q39710412-E55D0274-6B63-465F-AFF5-139522DA2C50

P2860

Q39710412-BA858901-4193-4146-8A66-749B7F7AF283

Q39710412-C15A0B5D-3275-45FA-9A2E-306494576F68

P2888

Q39710412-EE7B1501-3472-44F9-B3C0-10A1917A2802

P304

Q39710412-4A64527F-FC3D-4EAC-B7A3-DAD1CF69CF82

P31

Q39710412-2AD6931F-CD42-4AEE-ABB9-5F0DD73E9DBB

P356

Q39710412-3B221423-E9EB-4B18-A259-84B9F7854822

P433

Q39710412-8E4E7039-A882-4637-92DB-2EA1AEFCFB0F

P478

Q39710412-F976FAA9-B225-45FE-95AE-321F88A9F037

P50

Q39710412-5CD7F812-9A48-480D-B912-BA48D59F76C2

P577

Q39710412-E45EAD97-7A1C-4857-BBB9-2F7CD52AC8F0

P698

Q39710412-5E8B3D44-395B-49C3-88AA-BB23412B1630

P356

S11605-010-1202-2

P1433

Journal of Gastrointestinal Surgery

P1476

Altered expression of MiR-148a ...... and its clinical significance

@en

P2093

Chengzhong Xing

http://www.w3.org/2001/XMLSchema#string

Huimian Xu

http://www.w3.org/2001/XMLSchema#string

Yongxi Song

http://www.w3.org/2001/XMLSchema#string

Yue Chen

http://www.w3.org/2001/XMLSchema#string

Zhenyu Yue

http://www.w3.org/2001/XMLSchema#string

Zhuangkai Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer.

Stimulation of the gastrin-cholecystokinin(B) receptor promotes branching morphogenesis in gastric AGS cells.

P2888

s11605-010-1202-2

P304

1170-1179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11605-010-1202-2

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20422307

http://www.w3.org/2001/XMLSchema#string